{
    "clinical_study": {
        "@rank": "102359", 
        "arm_group": {
            "arm_group_label": "Ulthera-treated subjects", 
            "arm_group_type": "Experimental", 
            "description": "All enrolled subjects will receive one Ultherapy treatment to one side of the body in the lateral buttock region.  Following study completion, subjects may elect to receive a balancing treatment to the other side of the body."
        }, 
        "brief_summary": {
            "textblock": "Up to 30 subjects will be enrolled. Enrolled subjects will receive an Ulthera\u00ae treatment to\n      one side of the body, treating the lateral buttock region. Follow-up visits will occur at 90\n      and 180 days post-treatment. Study images will be obtained pre-treatment, immediately\n      post-treatment, and at each follow-up visit."
        }, 
        "brief_title": "Feasibility Study: Ulthera Treatment of the Buttocks and Thighs", 
        "completion_date": {
            "#text": "July 2013", 
            "@type": "Actual"
        }, 
        "condition": "Skin Laxity", 
        "condition_browse": {
            "mesh_term": "Cutis Laxa"
        }, 
        "detailed_description": {
            "textblock": "This is a prospective, single-center, pilot clinical trial to evaluate the efficacy of the\n      Ulthera\u00ae System to improve buttock and thigh skin laxity. Global Aesthetic Improvement Scale\n      scores and patient satisfaction questionnaires will be obtained."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Male or female, age 30 to 65 years.\n\n          -  Subject in good health.\n\n          -  Skin laxity in the buttocks and thighs.\n\n          -  Understands and accepts the obligation not to undergo any other procedures in the\n             areas to be treated and/or weight loss through the follow-up period.\n\n          -  Willingness and ability to comply with protocol requirements, including returning for\n             follow-up visits and abstaining from exclusionary procedures for the duration of the\n             study.\n\n          -  Subjects of childbearing potential must have a negative urine pregnancy test result\n             and must not be lactating at Visit 1 and be willing and able to use an acceptable\n             method of birth control (e.g., barrier methods used with a spermicidal agent,\n             hormonal methods, IUD, surgical sterilization, abstinence) during the study. Women\n             will not be considered of childbearing potential if one of the following conditions\n             is documented on the medical history: a) Postmenopausal for at least 12 months prior\n             to study; b) Without a uterus and/or both ovaries; or c) A bilateral tubal ligation\n             at least six months prior to study enrollment.\n\n        Exclusion Criteria:\n\n          -  Presence of an active systemic or local skin disease that may affect wound healing.\n\n          -  BMI equal to or greater than 40.\n\n          -  Excessive subcutaneous fat in the buttocks and thighs.\n\n          -  Excessive skin laxity in the buttocks and thighs.\n\n          -  Significant weight fluctuation (\u00b110 lbs) in the past 6 months.\n\n          -  Taking weight-loss medications/supplements.\n\n          -  Surgical or non-surgical treatments to the target areas in the last 12 months, e.g.,\n             liposuction.\n\n          -  Inability to understand the protocol or to give informed consent."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "65 Years", 
            "minimum_age": "30 Years"
        }, 
        "enrollment": {
            "#text": "31", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "October 15, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01708460", 
            "org_study_id": "ULT-118"
        }, 
        "intervention": {
            "arm_group_label": "Ulthera-treated subjects", 
            "description": "Focused ultrasound energy delivered below the surface of the skin.", 
            "intervention_name": "Ulthera System Treatment", 
            "intervention_type": "Device", 
            "other_name": "Ultherapy\u2122"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Ulthera\u00ae System", 
            "Ultherapy\u2122 Treatment", 
            "Ulthera, Inc.", 
            "Ultrasound treatment for skin tightening"
        ], 
        "lastchanged_date": "September 9, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "New York", 
                    "country": "United States", 
                    "state": "New York", 
                    "zip": "10022"
                }, 
                "name": "Skin Laser and Surgery Specialist of New York and New Jersey"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "Feasibility Study: Evaluation of the Ulthera\u00ae System for Lifting and Tightening the Buttocks and Thighs", 
        "overall_official": {
            "affiliation": "Skin Laser and Surgery Specialist of New York and New Jersey", 
            "last_name": "David Goldberg, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "As determined by a masked, qualitative assessment of photographs at three months post-treatment compared to baseline.", 
            "measure": "Overall lifting and tightening of the buttocks and thighs.", 
            "safety_issue": "No", 
            "time_frame": "90 days post-treatment"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01708460"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "As determined by GAIS completed by the Investigator and subject.", 
                "measure": "Overall aesthetic improvement.", 
                "safety_issue": "No", 
                "time_frame": "90 and 180 days post-treatment."
            }, 
            {
                "description": "As determined by subjects' completion of a Patient Satisfaction Questionnaire.", 
                "measure": "Overall subject satisfaction.", 
                "safety_issue": "No", 
                "time_frame": "90 and 180 days post-treatment"
            }
        ], 
        "source": "Ulthera, Inc", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Ulthera, Inc", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "December 2011", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "September 2013"
    }
}